Trials / Conditions / Locally Advanced Rectal Carcinoma

Locally Advanced Rectal Carcinoma

26 registered clinical trials studyying Locally Advanced Rectal Carcinoma — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by NCT07472868	J. W. A. Burger	Phase 3
Recruiting	Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer NCT07372300	Shih-Kai Hung	Phase 3
Active Not Recruiting	Reducing the Resection Range After Neoadjuvant Therapy for Locally Advanced Upper Rectal and Rectosigmoid Junc NCT07038122	Sixth Affiliated Hospital, Sun Yat-sen University	N/A
Not Yet Recruiting	Radiological Markers in Locally Advanced Rectal Cancer NCT06843655	IRCCS San Raffaele	—
Recruiting	Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer NCT06276686	University of Hull	EARLY_Phase 1
Withdrawn	Exercise for Improving Radiotherapy Efficacy in Rectal Cancer NCT06292975	University of Hull	N/A
Unknown	Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy NCT06304597	University Medical Center Groningen	Phase 1
Recruiting	A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer NCT06312982	Beijing Friendship Hospital	Phase 2 / Phase 3
Suspended	Endorectal Brachytherapy for Rectal Cancer NCT05591534	University Hospital, Bordeaux	Phase 2
Unknown	Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term C NCT05920928	Tehran University of Medical Sciences	N/A
Completed	MRI T1 Relaxation Time in Rectal Cancer NCT05876026	Vejle Hospital	—
Completed	Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cance NCT05792735	Shenzhen People's Hospital	Phase 2
Recruiting	Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer NCT05731726	Zhejiang University	Phase 2
Recruiting	Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer NCT05601505	Peking Union Medical College Hospital	Phase 2
Recruiting	Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side NCT05722288	City of Hope Medical Center	Phase 2
Not Yet Recruiting	Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer NCT05645094	Fudan University	—
Active Not Recruiting	Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After NCT05610163	Alliance for Clinical Trials in Oncology	Phase 2
Active Not Recruiting	Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer NCT05524012	Jena University Hospital	—
Recruiting	An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in L NCT05245786	City of Hope Medical Center	EARLY_Phase 1
Recruiting	Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local E NCT05772923	The Netherlands Cancer Institute	N/A
Terminated	Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) NCT04406857	National Cancer Institute (NCI)	Phase 1
Recruiting	Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer NCT04703101	Jonsson Comprehensive Cancer Center	Phase 1
Terminated	Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer NCT03280277	OHSU Knight Cancer Institute	EARLY_Phase 1
Completed	Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locall NCT05622357	National Cancer Institute, Egypt	Phase 2
Completed	Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer NCT06314737	Sixth Affiliated Hospital, Sun Yat-sen University	—
Completed	Deep Learning Based MRI Radiomics in Predicting the Clinical Risk of Locally Advanced Rectal Cancer NCT06314750	Sixth Affiliated Hospital, Sun Yat-sen University	—